A Ruhdorfer1, F Haniel2, T Petersohn3, J Dörrenberg4, W Wirth5, T Dannhauer6, D J Hunter7, F Eckstein8. 1. Institute of Anatomy, Paracelsus Medical University Salzburg & Nuremberg, Salzburg, Austria. Electronic address: anja.ruhdorfer@pmu.ac.at. 2. Institute of Anatomy, Paracelsus Medical University Salzburg & Nuremberg, Salzburg, Austria. Electronic address: franziska.haniel@pmu.ac.at. 3. Institute of Anatomy, Paracelsus Medical University Salzburg & Nuremberg, Salzburg, Austria. Electronic address: tobias.petersohn@pmu.ac.at. 4. Institute of Anatomy, Paracelsus Medical University Salzburg & Nuremberg, Salzburg, Austria. Electronic address: jan.doerrenberg@live.de. 5. Institute of Anatomy, Paracelsus Medical University Salzburg & Nuremberg, Salzburg, Austria; Chondrometrics GmbH, Ainring, Germany. Electronic address: wolfgang.wirth@pmu.ac.at. 6. Institute of Anatomy, Paracelsus Medical University Salzburg & Nuremberg, Salzburg, Austria; Chondrometrics GmbH, Ainring, Germany. Electronic address: torben.dannhauer@pmu.ac.at. 7. Rheumatology Department, Royal North Shore Hospital & Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia. Electronic address: david.hunter@sydney.edu.au. 8. Institute of Anatomy, Paracelsus Medical University Salzburg & Nuremberg, Salzburg, Austria; Chondrometrics GmbH, Ainring, Germany. Electronic address: felix.eckstein@pmu.ac.at.
Abstract
OBJECTIVE: To examine cross-sectional and longitudinal between-group differences of infra-patellar fat pad (IPFP) size and magnetic resonance imaging (MRI) signal from fat-suppressed intermediate-weighted images with clinically relevant symptomatic and radiographic progression of knee osteoarthritis (OA), vs healthy references. METHODS: We studied 110 case knees (Kellgren-Lawrence Grade [KLG1-3]) with radiographic (≥0.7 mm loss in joint space width [JSW]) and symptomatic progression (≥+9/100 units on the Western Ontario and McMasters Universities Osteoarthritis Index [WOMAC] knee pain subscale) vs 118 control knees without progression from the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium cohort. We further studied 88 knees from the Osteoarthritis Initiative (OAI) healthy reference cohort without (risk factors) of knee OA. The IPFP was manually segmented using baseline and year-2 sagittal fat-suppressed intermediate-weighted spin-echo 3 T MRIs. Baseline measures and longitudinal change in IPFP volume and 3D MRI signal (mean, standard deviation [SD]) were compared between groups. RESULTS: No statistically significant baseline differences in IPFP volume, 3D MRI signal mean or signal heterogeneity (SD) were observed between progressor and non-progressor OA knees. Yet, the IPFP 3D MRI signal SD, but not its volume, was statistically significantly greater in OA vs healthy knees. No statistically significant 2-year changes in IPFP volume were observed in either group, but the increase in 3D MRI signal heterogeneity (SD) was greater in progressor vs non-progressor knees, and was greater in OA vs healthy knees. CONCLUSION: Whereas IPFP-related morphometric measures did not statistically significantly differ between groups, a stronger increase in 3D IPFP MRI signal and signal heterogeneity may be associated with radiographic/symptomatic progression of OA, when compared to non-progressive OA or healthy knees.
OBJECTIVE: To examine cross-sectional and longitudinal between-group differences of infra-patellar fat pad (IPFP) size and magnetic resonance imaging (MRI) signal from fat-suppressed intermediate-weighted images with clinically relevant symptomatic and radiographic progression of knee osteoarthritis (OA), vs healthy references. METHODS: We studied 110 case knees (Kellgren-Lawrence Grade [KLG1-3]) with radiographic (≥0.7 mm loss in joint space width [JSW]) and symptomatic progression (≥+9/100 units on the Western Ontario and McMasters Universities Osteoarthritis Index [WOMAC] knee pain subscale) vs 118 control knees without progression from the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium cohort. We further studied 88 knees from the OsteoarthritisInitiative (OAI) healthy reference cohort without (risk factors) of knee OA. The IPFP was manually segmented using baseline and year-2 sagittal fat-suppressed intermediate-weighted spin-echo 3 T MRIs. Baseline measures and longitudinal change in IPFP volume and 3D MRI signal (mean, standard deviation [SD]) were compared between groups. RESULTS: No statistically significant baseline differences in IPFP volume, 3D MRI signal mean or signal heterogeneity (SD) were observed between progressor and non-progressor OA knees. Yet, the IPFP 3D MRI signal SD, but not its volume, was statistically significantly greater in OA vs healthy knees. No statistically significant 2-year changes in IPFP volume were observed in either group, but the increase in 3D MRI signal heterogeneity (SD) was greater in progressor vs non-progressor knees, and was greater in OA vs healthy knees. CONCLUSION: Whereas IPFP-related morphometric measures did not statistically significantly differ between groups, a stronger increase in 3D IPFP MRI signal and signal heterogeneity may be associated with radiographic/symptomatic progression of OA, when compared to non-progressive OA or healthy knees.
Authors: Frank W Roemer; C Kent Kwoh; Michael J Hannon; David J Hunter; Felix Eckstein; Tomoko Fujii; Robert M Boudreau; Ali Guermazi Journal: Arthritis Rheumatol Date: 2015-05 Impact factor: 10.995
Authors: Elena Losina; Rochelle P Walensky; William M Reichmann; Holly L Holt; Hanna Gerlovin; Daniel H Solomon; Joanne M Jordan; David J Hunter; Lisa G Suter; Alexander M Weinstein; A David Paltiel; Jeffrey N Katz Journal: Ann Intern Med Date: 2011-02-15 Impact factor: 25.391
Authors: I R Klein-Wieringa; M Kloppenburg; Y M Bastiaansen-Jenniskens; E Yusuf; J C Kwekkeboom; H El-Bannoudi; R G H H Nelissen; A Zuurmond; V Stojanovic-Susulic; G J V M Van Osch; R E M Toes; A Ioan-Facsinay Journal: Ann Rheum Dis Date: 2011-01-17 Impact factor: 19.103
Authors: F W Roemer; M Jarraya; D T Felson; D Hayashi; M D Crema; D Loeuille; A Guermazi Journal: Osteoarthritis Cartilage Date: 2015-10-09 Impact factor: 6.576
Authors: Jamie E Collins; Elena Losina; Michael C Nevitt; Frank W Roemer; Ali Guermazi; John A Lynch; Jeffrey N Katz; C Kent Kwoh; Virginia B Kraus; David J Hunter Journal: Arthritis Rheumatol Date: 2016-10 Impact factor: 10.995
Authors: W Wirth; M Nevitt; M-P Hellio Le Graverand; J Lynch; S Maschek; M Hudelmaier; F Eckstein Journal: Osteoarthritis Cartilage Date: 2013-11-01 Impact factor: 6.576
Authors: Rianne A van der Heijden; Bas A de Vries; Dirk H J Poot; Marienke van Middelkoop; Sita M A Bierma-Zeinstra; Gabriel P Krestin; Edwin H G Oei Journal: Quant Imaging Med Surg Date: 2021-01